Has there even ever been a pressing requirement for unmanned low-g wide-crossrange reentry? This looks like another one of those solutions to an inexisting problem that are so common in the "new space" sectorIt seems to me that anything that was robust enough to be brought up on a rocket should be capable of coming down in a Dragon. There might be a handful of exceptions that could benefit from low-g reentry, but wouldn't it be cheaper to design a special packaging for those experiments rather than a whole new reentry vehicle?
Time Sensitive. Think biological samples.
This seems bizarre to me - but what do I know. - What tiny/small payload is so time critical that this becomes economical? - It will take up significant pressurized payload space (& mass) going up - Handling this thing *inside* ISS seems dangerous.But again, I could be way off base.
Quote from: mfck on 10/20/2014 08:02 amTime Sensitive. Think biological samples.Surely you could schedule such a time-sensitive experiment so that the samples are ready just before closing the hatch on a Dragon, or you could plan them to go up and down on a crew rotation. In any case, it sounds like a tiny niche that doesn't justify a whole new reentry vehicle to be developed.Has such a need actually been formulated by a science team? Or is it a fantasy requirement made up to fit the idea.
Quote from: Lars-J on 10/20/2014 04:28 amThis seems bizarre to me - but what do I know. - What tiny/small payload is so time critical that this becomes economical? - It will take up significant pressurized payload space (& mass) going up - Handling this thing *inside* ISS seems dangerous.But again, I could be way off base.Reentry opportunities are only quarterly at best. For commercial research they often need as fast of iteration cycles as they can get, and right now the current transportation can mean only 1-2 cycles per year. Even though microgravity is amazing, if you force research to stretch out over too much time, it can be better to use a lower quality research environment that you can access frequently.It is true though that it will take up significant payload mass and space to make this happen. ~Jon
Industry-wide research and investment reached a record $65.3 billion in 2009. While the cost of research in the U.S. was about $34.2 billion between 1995 and 2010, revenues rose faster (revenues rose by $200.4 billion in that time)
That won't happen at ISS. Also, pharma R&D is a much smaller market than the total space industry which is hundreds of billions.
Quote from: jongoff on 10/20/2014 08:12 pmQuote from: Lars-J on 10/20/2014 04:28 amThis seems bizarre to me - but what do I know. - What tiny/small payload is so time critical that this becomes economical? - It will take up significant pressurized payload space (& mass) going up - Handling this thing *inside* ISS seems dangerous.But again, I could be way off base.Reentry opportunities are only quarterly at best. For commercial research they often need as fast of iteration cycles as they can get, and right now the current transportation can mean only 1-2 cycles per year. Even though microgravity is amazing, if you force research to stretch out over too much time, it can be better to use a lower quality research environment that you can access frequently.It is true though that it will take up significant payload mass and space to make this happen. ~JonBut it doesn't provide more re-entry opportunities, really, it provides *one* additional one for a very small cargo. It would be one thing if they could be launched on a small & cheap sat launcher to rendezvous with ISS on its own, then you can send up as many as you want. But stocking up multiple of these inside ISS just isn't practical. Nor can we reasonably expect multiple of these to be sent up on each CRS mission to realize those frequent downmass opportunities.
It doesn't matter how big the pharmaceutical industry is if zero-g won't help them with what they're trying to do. CASIS has been trying to get industry to use the ISS for anything it can, but so far it's found close to zero interest.Maybe there's a lack of understanding in the industry or maybe CASIS has done a poor job. But there's also the possibility that zero-g just isn't useful for developing drugs.
Quote from: ChrisWilson68 on 10/21/2014 03:34 amIt doesn't matter how big the pharmaceutical industry is if zero-g won't help them with what they're trying to do. CASIS has been trying to get industry to use the ISS for anything it can, but so far it's found close to zero interest.Maybe there's a lack of understanding in the industry or maybe CASIS has done a poor job. But there's also the possibility that zero-g just isn't useful for developing drugs.The bigger problem is that the Congressional legislation that created the National Lab required them to retain IP and data rights for all research run through the national lab. They got some relief on the IP part, but not yet on the data rights. Because of that pharma researchers have largely kept their research to-date focused on unpatentable basic research. CASIS is trying to get relief on this (I think one or both of the NASA Authorization bills working their way through Congress address this), especially since NASA had previously waved this requirement for other organizations like NanoRacks. ~Jon
Quote from: Zed_Noir on 10/19/2014 10:58 amHow is the Intuitive Machines ISS RV defined by ITARS? Is it consider munitions to be regulated by ITARS?Isn't everything, these days? You'd have a really hard time selling just cubesat parts in the US without running in to eyeTAR, let alone a guided reentry vehicle.
How is the Intuitive Machines ISS RV defined by ITARS? Is it consider munitions to be regulated by ITARS?
...Launch vehicle technology and launches themselves have specific breakout language in ITAR.(6) A launch vehicle or payload shall not, by reason of the launching of such vehicle, be considered an export for purposes of this subchapter. However, for certain limited purposes (see §126.1 of this subchapter), the controls of this subchapter may apply to any sale, transfer or proposal to sell or transfer defense articles or defense services. ITAR Matters when you try to export, share, or relinquish control over an item or even an idea to an entity or someone who is not a U.S. Citizen or an entity on the exempt list. So these guys can sell their ships in the U.S. without bumping into ITAR so long as the above requirement is met. They can't, however build or originate the machine in the US without bumping into ITAR if they try to show it off, sell it, or transfer control to a foreign entity. They can launch it and recover it (even on foreign soil) so long as it remains in the custody of U.S. personnel, but- as Jim has pointed out before- the chain of custody would have to be approved, and that's tricky.Here's the list: https://www.pmddtc.state.gov/regulations_laws/documents/official_itar/2014/ITAR_Part_121.pdf